TSOI JadiCells COVID-19 must read $$$$$coming JadiCells were found to be safe and show early evidence of effectiveness in COVID-19 patients who were on ventilation at a hospital’s intensive care unit. The U.S. Food and Drug Administration subsequently cleared the company to start a pivotal Phase 3 clinical trial in people with COVID-19 and associated lung failure. https://copdnewstoday.com/2021/09/02/therapeutic-solutions-patent-jadicells-copd-stem-cell-therapy/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.